Opening Discussion: What Value Do EEG Biomarkers Offer as Translational Tools for Neuropsychiatric Drug Development?
Time: 9:10 am
day: EEG Focus Day
Details:
What are the potential, or anticipated challenges, of leveraging EEG data to:
- Optimize dose selection: is EEG a relevant biomarker to leverage as a way of predicting and scaling therapeutic doses from animals into humans?
- Aid patient selection: how can EEG monitoring be optimized as an objective tool for patient stratification?
- Utilize as an outcome marker: is it beneficial to collect clinical EEG data as an additional endpoint?
